MedPath

To evaluate the effect of reduction in thickness of uterine cavity lining on pregnancy outcome

Phase 4
Conditions
Health Condition 1: N979- Female infertility, unspecified
Registration Number
CTRI/2021/02/031397
Lead Sponsor
Craft Hospital and Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Women undergoing frozen embryo transfer with

HRT protocol for endometrial preparation

2.Endometrial thickness more than or equal to 8mm on day of starting progesterone

Exclusion Criteria

1.Endometrial preparation with natural/modified natural cycle

2.Thin endometrium (less than 8 mm on day of progesterone administration)

3.Cases with only poor quality embryo

4.Women with congenital and untreated acquired uterine anomaly

5.Women with thrombophilia

6.Women with untreated hydrosalpinx

7.Couple with genetic and chromosomal abnormality

8.Women with BMI >/30

9.Uncontrolled endocrine or haematological

dysfunction

10.Women undergoing PGT cycles

11.Those who had difficult embryo transfer in the index cycle

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath